Sai Parenterals is a diversified pharmaceutical formulations company with integrated capabilities in research, development and manufacturing. The company operates across two key business segments: branded generic formulations and contract development and manufacturing organisation (CDMO) products and services, catering to both domestic and international markets. Its product portfolio spans multiple therapeutic areas including cardiovascular, neuropsychiatry, anti-diabetic, respiratory health, antibiotics, gastroenterology, vitamins, minerals and supplements (VMS), analgesics and dermatology. Sai Parenterals offers formulations across a wide range of dosage forms such as injectables, tablets, capsules, liquid orals and ointments. In the injectables segment, the company possesses sterile manufacturing capabilities for critical care and penicillin-based therapies, with delivery systems including dry powder injections, pre-filled syringes, ampoules and vials, enabling it to meet stringent quality and regulatory requirements.
Price Band₹ |
Listing AtNSE & BSE |
IPO Issue Type100% Book Built Offer |
Fresh Issue₹285.00 Cr (0.00 Shares) |
Offer For Sale₹0.00 (0.35 Cr Shares) |
Total Issue₹285.00 Cr (0.35 Cr Shares) |
Face Value₹5 per equity share |
| Particulars | Allocation |
|---|---|
| QIBs | Not more than 50% of Net Offer |
| Big HNIs (NII) | Not less than 10% of Net Offer |
| Small HNIs (NII) | Not less than 5% of Net Offer |
| Retail | Not less than 35% of Net Offer |
| KPI | VALUES |
|---|---|
| EBITDA | 24.18% |
| PAT | 8.90% |
| RONW | 15.09% |
| ROCE | 28.90% |
| Name | Shareholding |
|---|---|
| Anil Karusala | 12.35% |
| Vijitha Gorrepati | 34.61% |
| Karusala Aruna | 8.85% |
| Kunal Kakumanu | 5.42% |
| Total | 61.23% |
| Name | Designation |
|---|---|
| Anil Karusala | Chairman & MD |
| D B Prakash | CEO |
| Anil Kumar | CFO |
Name: Sai Parenteral'S Limited
Address: Plot No 39, 5th floor, Lavanya Arcade Jayabheri Enclave, Gachibowli, K.V.Rangareddy, Seri Lingampally, Telangana, India, 500032
Number: +91 79979 91301
Email: cs@saiparenterals.com
Website: https://sww.saiparenterals.com/
Frequently Asked questions?
Find answers to common questions that come in your mind related to IPO.
Sai Parenteral'S IPO is a Mainboard IPO having an issue size of Rs. ₹285.00 Crs. Sai Parenteral'S IPO is priced at ₹ - ₹ per share. The issue opens on 11 Feb 26 and closes on 11 Feb 26.
Sai Parenteral'S IPO opens on 11 Feb 26 and closes on 11 Feb 26.
The estimated Grey Market Premium of Sai Parenteral'S IPO is ₹0 per share (-).
The minimum lot size of Sai Parenteral'S IPO is shares & the minimum application amount is Rs. 0.
The allotment date of Sai Parenteral'S IPO is 11 Feb 26.
The listing date of Sai Parenteral'S IPO is 11 Feb 26.
Sai Parenteral'S IPO is subscribed -.
Sai Parenteral'S IPO is priced at ₹ - ₹ per share.
Click the allotment link on Sai Parenteral'S IPO page of IPO360.